Ayawan, Nancy L.
HRN: 01-38-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
CEFUROXIME 500MG (TAB)
12/17/2022
12/24/2022
PO
500mg
BID X 7 Days
S/P Excision Of Vaginal Mass Under SAB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes